STING1 and neoplasm: STING ADCs promote multiple aspects of innate and adaptive anti-tumor immune responses, including the activation of dendritic cells, T cells, NK cells, NK T cells and the promotion of M2 to M1 polarization of tumor-associated macrophages (98).